FDA Approved: LANOXIN — Supplemental Application (Advanz Pharma (US) Corp.)

View source ↗

Summary

The FDA approved a supplemental application for Lanoxin (digoxin) from Advanz Pharma US Corp., associated with NDA 020405. The supplement may involve changes to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Heart Failure

Drugs mentioned

• LANOXIN (Digoxin)

Snippet

SUPPL AP for LANOXIN (DIGOXIN)